SCHEMBL24316419

SCHEMBL24316419

COc1cc(O)cnc1OCc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRB P09619 1/20 0.49
PDGFRA P16234 1/20 0.49
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
LMNA P02545 3/20 0.45
MAOB P27338 1/20 0.45
MGAM O43451 1/20 0.45
GAA P10253 1/20 0.45
SI P14410 1/20 0.45
MGAM2 Q2M2H8 1/20 0.45
SLC6A4 P31645 1/20 0.45
HPGD P15428 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ALDH1A1 P00352 2/20 0.44
HTT P42858 2/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24316412 0.87 CYP11B1 (0.48)
SCHEMBL24316420 0.86 MAOB (0.45) MAPTLMNAMAOBHPGDNPC1
SCHEMBL21327653 0.86 CSF1R (0.54) PDGFRBPDGFRALMNAMAOBNPC1
SCHEMBL24316985 0.85 MRGPRX4 (0.49) KDM4EMAPTLMNAMAOBNPC1
SCHEMBL24316986 0.84 KDM4E (0.50) KDM4EMAPTLMNAMAOBHPGD
SCHEMBL17593325 0.83 PDGFRB (0.48) PDGFRBPDGFRALMNAMAOBSLC6A4
SCHEMBL24007661 0.82 LIPE (0.48) PDGFRBPDGFRAKDM4EMAPTLMNA
SCHEMBL24316988 0.81 CHRM4 (0.41) KDM4EMAPTLMNANPC1RAB9A
SCHEMBL24316418 0.80 CSF1R (0.41)
SCHEMBL24316417 0.80 TAAR1 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022057895-A1 HETEROAROMATIC COMPOUNDS AND USES THEREOF HUTCHISON MEDIPHARMA LIMITED (CN) 2022-03-24 WO disclosed
US-9585884-B2 Pyrimidinone inhibitors of lipoprotein-associated phospholipase A2 AUSPEX PHARMACEUTICALS, INC. (US) 2017-03-07 US disclosed